- BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
- BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)
- BIO-TECHNE DECLARES DIVIDEND
- BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
- BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS
- BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC
- BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY
- BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
- BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS
- BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY
More ▼
Key statistics
On Thursday, Bio-Techne Corp (TECH:NSQ) closed at 82.84, -7.86% below its 52-week high of 89.91, set on Jul 21, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 83.15 |
---|---|
High | 83.82 |
Low | 82.32 |
Bid | 49.80 |
Offer | 95.00 |
Previous close | 82.84 |
Average volume | 1.16m |
---|---|
Shares outstanding | 157.58m |
Free float | 156.05m |
P/E (TTM) | 64.34 |
Market cap | 12.75bn USD |
EPS (TTM) | 1.26 USD |
Annual div (ADY) | 0.32 USD |
---|---|
Annual div yield (ADY) | 0.39% |
Div ex-date | May 10 2024 |
Div pay-date | May 24 2024 |
Data delayed at least 15 minutes, as of May 16 2024 21:15 BST.
More ▼